Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAUTICA: Nitrofurantoin for CAUTI Prevention
NCT03287089Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Sep 2017
- Primary completion
- May 2019
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in catheter-associated urinary tract infection (CAUTI) comparing Nitrofurantoin with Placebo (2 arms). Primary endpoint: Catheter-Associated Urinary Tract Infection at 30 days. Started Sep 2017; status: completed.
02
Drugs
nitrofurantoin
03
Conditions
catheter-associated urinary tract infection (CAUTI)
Beyond the preview
Go deeper on NCT03287089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03287089.